News from pharnext sas A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

08 Jan, 2015, 10:00 GMT Pharnext's Pleotherapy Shows Synergistic Effects with PXT-864 in Alzheimer's Disease through Preclinical Data Published in Nature's Scientific Reports

Pharnext SAS today announced the publication of preclinical results in Nature's Scientific Reports for its lead pleodrug, PXT-864, in Alzheimer's...


18 Dec, 2014, 01:00 GMT Pharnext Announces Pleotherapy Proof of Concept in Charcot-Marie-Tooth Disease Type 1A through Two Peer-Reviewed Publications

Pharnext SAS today announced the proof of concept of its pleotherapy research and development approach based on a proprietary network pharmacology...


09 Dec, 2014, 07:00 GMT Pharnext announces the nomination of Michel de Rosen, a Pharmaceutical and Biotechnology Industry Leader, to its Board of Directors

Pharnext SAS, today announced the nomination of Michel de Rosen to its board of directors. The wealth of expertise Michel de Rosen has cultivated...


30 Jun, 2014, 12:36 BST Ipsen se une al consejo de administración de Pharnext

Pharnext SAS anunció hoy que Ipsen se ha unido a su consejo de dirección. Lo más destacado Ipsen estará representada por el consejo de dirección de...


30 Jun, 2014, 07:00 BST Ipsen joins Pharnext's Board of Directors

Pharnext SAS announced today that Ipsen has joined its Board of Directors. Highlights Ipsen will be represented on Pharnext's board of directors by...


23 Jun, 2014, 07:00 BST The EMA and FDA Grant Orphan Drug Designation to Pharnext's PXT-3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A

Pharnext SAS today announced that the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug...